Key result
Whole genome sequencing reveals Xp21.3p21.1 CGDS in a child with elevated CK misdiagnosed with adrenal insufficiency.
Case Report
In patients presenting with primary adrenal insufficiency alongside elevated creatinine kinase and triglycerides, whole genome sequencing can expedite the diagnosis of Xp21.3-p21.2 contiguous gene deletion syndrome.
Answers are grounded in this paper and cite their sources.
Supports consideration of WGS in adrenal insufficiency with elevated CK and triglycerides; extends diagnostic utility in rare genetic syndromes.
INTRODUCTION: Contiguous gene deletion syndromes (CGDSs) can be inherited or the result of microdeletions (eg, resulting from crossing-over errors) in gene-rich chromosome regions. Molecular mechanisms leading to chromosome loss in hotspot areas, such as errors in chromosome crossing-over events, can explain phenotypic presentations in CGDSs. Accurate interpretation of laboratory results in the context of clinical presentation can guide genetic testing that supports a timely diagnosis so that quicker interventions can improve clinical outcomes. Treatment of genetic disorders not only requires timely and accurate treatment, however, but also necessitates management and education of family members who care for the patient. Xp21.3-p21.2 deletion syndrome is a CGDS that has been documented in more than 100 male patients; it presents with primary adrenal insufficiency in the neonatal period. METHODS: Here, we report the largest Xp21.3-p21.2 CGDS series to date. RESULTS AND DISCUSSION: Initial presentation was incorrectly diagnosed as adrenal insufficiency only, despite excessively elevated creatinine kinase and triglycerides, which could have expedited the correct diagnosis of Xp21.3p21.1 CGDS by guiding whole genome or targeted sequencing.
No takes yet. Share an insight, caveat, or question.
Abadie et al. (2026) conducted a case report in Xp21.3-p21.2 contiguous gene deletion syndrome. Whole genome sequencing was evaluated. Whole genome sequencing guided the correct diagnosis of Xp21.3-p21.2 contiguous gene deletion syndrome in a presentation initially misdiagnosed as isolated adrenal insufficiency.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: